Concepedia

Elie W. Akl

EW

Statistics

Publications

9

Citations

553

H-Index

9

Active since

2021

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Marche Polytechnic University

Dana-Farber Brigham Cancer Center

Elie W. Akl is an author at Brigham and Women's Hospital specializing in medicine, cancer genomics, and molecular oncology.

Publications per year

2021–2024

9

Publications

9

<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid Tumors

Elio Adib, Amin H. Nassar, Elie W. Akl et al. · Clinical Cancer Research · 2021 · 129 citations · Full text

, , +17

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors

Amin H. Nassar, Elio Adib, Sarah Abou Alaiwi et al. · Cancer Cell · 2022 · 116 citations · Full text

, , +17

TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism

Nicola Alesi, Elie W. Akl, Damir Khabibullin et al. · Nature Communications · 2021 · 102 citations · Full text

, , +17

Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology

Elio Adib, Amin H. Nassar, Sarah Abou Alaiwi et al. · Genome Medicine · 2022 · 72 citations · Full text

, , +17

TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex

Nicola Alesi, Damir Khabibullin, Dean M. Rosenthal et al. · Nature Communications · 2024 · 45 citations · Full text

, , +16

1–5 of 9